Insight Molecular Diagnostics (IMDX) Current Leases (2016 - 2023)
Insight Molecular Diagnostics' (IMDX) quarterly Current Leases came in at $628000.0 in Q4 2023, up 156.33% quarter-over-quarter from $245000.0 in Q2 2019.
Insight Molecular Diagnostics (IMDX) Current Leases (2016 - 2023) Analysis & Trends
Insight Molecular Diagnostics has disclosed Current Leases across 5 years of filings, most recently posting $628000.0 for Q4 2023.
- Current Leases for Q4 2023 came in at $628000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2023 was $628000.0 (changed N/A YoY), and the FY2023 annual result was $628000.0, changed N/A from the prior year.
- Current Leases came in at $628000.0 for Q4 2023 at Insight Molecular Diagnostics, up from $245000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $628000.0 in Q4 2023 to a low of $245000.0 in Q2 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | 53.00 Mn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | - |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | - |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | - |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | - |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | - |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | - |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | - |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | - |
| 10 | Insight Molecular Diagnostics | 4.52 Mn | -24.41 Mn | 15,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 628,000.00 |
| Jun 30, 2019 | 245,000.00 |
| Mar 31, 2019 | 304,000.00 |
| Dec 31, 2018 | 385,000.00 |
| Sep 30, 2018 | 471,000.00 |
| Jun 30, 2018 | 310,000.00 |
| Mar 31, 2018 | 346,000.00 |
| Dec 31, 2017 | 338,000.00 |
| Sep 30, 2017 | 304,000.00 |
| Jun 30, 2017 | 297,000.00 |
| Mar 31, 2017 | 202,000.00 |
| Dec 31, 2016 | 202,000.00 |
| Sep 30, 2016 | 173,000.00 |
| Jun 30, 2016 | 173,000.00 |